Evolving chemotherapeutics

ASCO 2017 – Detailed clinical trial results presented

Professor Phil Clingan

The phase 1 trial results were presented in greater detail in two posters at ASCO 2017 in Chicago this week.

Professor Phil Clingan presented a poster: Deflexifol (a novel formulation of 5FU) Phase 1 Dose Escalation Study of Infusional or Bolus Schedules After Failure of Standard Treatment

Clingan P. et al J Clin Oncol 35, 2017 (suppl; abstr 2529) http://abstracts.asco.org/199/AbstView_199_188458.html

Professor Stephen Ackland presented another poster about the trial:  Deflexifol (a novel formulation of 5FU): Pharmacokinetics in a Phase 1 Trial in Comparison to 5FU

Ackland S. et al J Clin Oncol 35, 2017 (suppl; abstr 2530) http://abstracts.asco.org/199/AbstView_199_189228.html.